Lee Frego

719 total citations
18 papers, 506 citations indexed

About

Lee Frego is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Lee Frego has authored 18 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Immunology and 5 papers in Oncology. Recurrent topics in Lee Frego's work include Immunotherapy and Immune Responses (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and CAR-T cell therapy research (3 papers). Lee Frego is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and CAR-T cell therapy research (3 papers). Lee Frego collaborates with scholars based in United States, Germany and Austria. Lee Frego's co-authors include Walter Davidson, Rachel Kroe‐Barrett, S.M. Margarit, C. Erec Stebbins, Mark E. Labadia, Gregory W. Peet, Brian Werneburg, Susan Lukas, Sanjaya Singh and Christopher Pargellis and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Analytical Chemistry.

In The Last Decade

Lee Frego

17 papers receiving 499 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lee Frego United States 12 226 156 81 64 52 18 506
Masafumi Kamada Japan 15 277 1.2× 207 1.3× 70 0.9× 33 0.5× 37 0.7× 39 759
Therese Dau Germany 10 437 1.9× 167 1.1× 38 0.5× 35 0.5× 139 2.7× 18 670
Reinhard Kodym Austria 13 459 2.0× 101 0.6× 169 2.1× 30 0.5× 12 0.2× 29 802
Éric Winstall Canada 13 442 2.0× 124 0.8× 203 2.5× 34 0.5× 43 0.8× 15 626
Woubalem Birmachu United States 10 244 1.1× 170 1.1× 47 0.6× 17 0.3× 19 0.4× 13 494
Paul Kearney United States 13 176 0.8× 72 0.5× 79 1.0× 33 0.5× 109 2.1× 25 578
Jingyu Wu China 13 481 2.1× 159 1.0× 77 1.0× 28 0.4× 71 1.4× 43 825
M. Di Vito Italy 11 271 1.2× 55 0.4× 54 0.7× 20 0.3× 38 0.7× 11 495
Gregory E. Arnold United States 16 332 1.5× 235 1.5× 110 1.4× 36 0.6× 45 0.9× 24 750
Jacintha Shenton United States 13 253 1.1× 179 1.1× 153 1.9× 23 0.4× 18 0.3× 18 753

Countries citing papers authored by Lee Frego

Since Specialization
Citations

This map shows the geographic impact of Lee Frego's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee Frego with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee Frego more than expected).

Fields of papers citing papers by Lee Frego

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lee Frego. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee Frego. The network helps show where Lee Frego may publish in the future.

Co-authorship network of co-authors of Lee Frego

This figure shows the co-authorship network connecting the top 25 collaborators of Lee Frego. A scholar is included among the top collaborators of Lee Frego based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lee Frego. Lee Frego is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kiechle, Tobias, Heike Neubauer, Birgit Stierstorfer, et al.. (2024). GPR180 is a new member of the Golgi-dynamics domain seven-transmembrane helix protein family. Communications Biology. 7(1).
2.
Wei, Yangjie, Dongmei Liu, Lee Frego, et al.. (2022). Effect of the ADCC-Modulating Mutations and the Selection of Human IgG Isotypes on Physicochemical Properties of Fc. Journal of Pharmaceutical Sciences. 111(9). 2411–2421. 1 indexed citations
3.
Zettl, Markus, Melanie Wurm, Otmar Schaaf, et al.. (2022). Combination of two novel blocking antibodies, anti-PD-1 antibody ezabenlimab (BI 754091) and anti-LAG-3 antibody BI 754111, leads to increased immune cell responses. OncoImmunology. 11(1). 2080328–2080328. 18 indexed citations
4.
Li, Hua, Zhong-Fu Huang, Dongmei Liu, et al.. (2021). An optimally designed anti-human CD40 antibody with potent B cell suppression for the treatment of autoimmune diseases. International Journal of Pharmaceutics. 609. 121162–121162. 8 indexed citations
5.
Reboll, Marc R., Mortimer Korf‐Klingebiel, Priyanka Gupta, et al.. (2019). Crystal structure and receptor-interacting residues of MYDGF — a protein mediating ischemic tissue repair. Nature Communications. 10(1). 5379–5379. 21 indexed citations
6.
Löw, Sarah, Bernd Weigle, Darrin Dutcher, et al.. (2018). Design and characterization of Zweimab and Doppelmab, high affinity dual antagonistic anti-TSLP/IL13 bispecific antibodies. Biochemical and Biophysical Research Communications. 504(1). 19–24. 40 indexed citations
7.
Zettl, Markus, Melanie Wurm, Otmar Schaaf, et al.. (2018). Abstract 4547: Characterization of the LAG-3 targeting antibody BI 754111 in monotherapy and in combination with the anti-PD-1 antibody BI 754091. Cancer Research. 78(13_Supplement). 4547–4547. 4 indexed citations
8.
Zettl, Markus, Melanie Wurm, Otmar Schaaf, et al.. (2018). Abstract 4558: In vitro and in vivo characterization of the PD-1 targeting antibody BI 754091. Cancer Research. 78(13_Supplement). 4558–4558. 1 indexed citations
9.
Yang, Danlin, et al.. (2016). Efficient Qualitative and Quantitative Determination of Antigen-induced Immune Responses. Journal of Biological Chemistry. 291(31). 16361–16374. 13 indexed citations
10.
Singh, Sanjaya, Rachel Kroe‐Barrett, Keith A. Canada, et al.. (2015). Selective targeting of the IL23 pathway: Generation and characterization of a novel high-affinity humanized anti-IL23A antibody. mAbs. 7(4). 778–791. 94 indexed citations
11.
Margarit, S.M., Walter Davidson, Lee Frego, & C. Erec Stebbins. (2006). A Steric Antagonism of Actin Polymerization by a Salmonella Virulence Protein. Structure. 14(8). 1219–1229. 73 indexed citations
12.
Frego, Lee, et al.. (2006). The determination of high‐affinity protein/inhibitor binding constants by electrospray ionization hydrogen/deuterium exchange mass spectrometry. Rapid Communications in Mass Spectrometry. 20(16). 2478–2482. 5 indexed citations
14.
Lukas, Susan, Rachel Kroe‐Barrett, Gregory W. Peet, et al.. (2004). Catalysis and Function of the p38α·MK2a Signaling Complex. Biochemistry. 43(31). 9950–9960. 47 indexed citations
15.
Davidson, Walter, Lee Frego, Gregory W. Peet, et al.. (2004). Discovery and Characterization of a Substrate Selective p38α Inhibitor. Biochemistry. 43(37). 11658–11671. 89 indexed citations
16.
Davidson, Walter, Graham A. McGibbon, Peter W. White, et al.. (2004). Characterization of the Binding Site for Inhibitors of the HPV11 E1−E2 Protein Interaction on the E2 Transactivation Domain by Photoaffinity Labeling and Mass Spectrometry. Analytical Chemistry. 76(7). 2095–2102. 18 indexed citations
17.
Davidson, Walter & Lee Frego. (2002). Micro‐high‐performance liquid chromatography/Fourier transform mass spectrometry with electron‐capture dissociation for the analysis of protein enzymatic digests. Rapid Communications in Mass Spectrometry. 16(10). 993–998. 25 indexed citations
18.
Hennessey, Todd M., Lee Frego, & Joseph T. Francis. (1994). Oxidants act as chemorepellents in Paramecium by stimulating an electrogenic plasma membrane reductase activity. Journal of Comparative Physiology A. 175(5). 655–65. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026